The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome

Journal of Pediatrics

Volumn 132, Issue 1, 1998, Pages 48-52

  Tapia, J L ^a   Ramirez, R ^a   Cifuentes, J ^a   Fabres, J ^a   Hubner, M E ^a   Bancalari, A ^a   Mercado, M E ^a   Standen, J ^a   Escobar, M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EARLY DIAGNOSIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

EID: 0031918557     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70483-4     Document Type: Article

References (36)

1. HL. Halliday Surfactant replacement therapy Pediatr Pulmonol S1 1995 96 97
2. HM Hennes MB Lee AA Rimm DL. Shapiro Surfactant replacement therapy in respiratory distress syndrome. Meta-analysis of clinical trials of single-dose surfactant extracts Am J Dis Child 145 1991 102 104
3. RM Schwartz AM Luby JW Scanlon RJ. Kellogg Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500 to 1500 g N Engl J Med 330 1994 1476 1480
4. RF Soll TA Merritt M. Hallman Surfactant in the prevention and treatment of respiratory distress syndrome BR Boynton WA Carlo AM Jobe New therapies for neonatal respiratory failure. 1994 Cambridge University Press Cambridge (England) 49 80
5. JL Tapia A Oto R Ramirez MT Henriquez P Fernandez J Alvarez Terapia con surfactante exógeno en recién nacidos con enfermedad de membrana hialina Rev Chil Pediatr 65 1994 137 142
6. ME Avery WH Tooley J Keller S Hurd H Bryan R Cotton Is chronic lung disease in low birth weight infants preventable? A survey of eight centers Pediatrics 79 1987 26 30
7. WH. Northway An introduction to bronchopulmonary dysplasia Clin Perinatol 19 1992 489 495
8. JL Tapia I Sánchez X Lara G Aguayo Incidencia de displasia broncopulmonar Rev Chil Pediatr 61 1987 130 134
9. E Bancalari I. Sosenko Pathogenesis and prevention of neonatal chronic lung disease: recent developments Pediatr Pulmonol 8 1990 109 116
10. M Mammel T Green D Johnson TR. Thompson Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia Lancet 1 1983 1356 1358
11. G Avery A Fletcher M Kaplan S. Brudno Controlled trial of dexamethasone in respiratory dependent infants with bronchopulmonary dysplasia Pediatrics 75 1985 106 111
12. Collaborative Dexamethasone Trial Group Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial Pediatrics 88 1991 4212 4227
13. J Davis R Sinkin J. Aranda Drug therapy for bronchopulmonary dysplasia Pediatr Pulmonol 8 1990 117 125
14. NY Kazzi YW Brans RL. Poland Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependant on artificial ventilation Pediatrics 82 1990 722 727
15. TA Merrit YD Stuard J Puccia B Wood DK Edwards J Finkelstein Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia J Pediatr 98 1981 949 956
16. B Ogden S Murphy G Saunders D Pathak J. Johnson Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance Am Rev Respir Dis 130 1984 817 821
17. JS Gerdes C Yoder SD Douglas M Paul MC Harris RA. Polin Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia J Pediatr 108 1986 601 606
18. TF Yeh JA Torre A Rastogi MA Anyebuno R. Pildes Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study J Pediatr 117 1990 273 282
19. The OSIRIS Collaborative Group Early versus delayed administration of a synthetic surfactant-the judgment of OSIRIS Lancet 340 1992 1363 1369
20. A Bancalari G Abdenour R Feller J. Gannon Bronchopulmonary dysplasia: clinical presentation J Pediatr 95 1979 819 822
21. L Papile J Burstein R Burstein H. Koffer Incidence and evolution of subependymal and intraventricular hemorrhage. A study of infants with birth weights less than 1500 grams J Pediatr 92 1978 529 534
22. JD Horbar TL McAuliffe SM Adler S Albersheim G Cassady W Edwards Variability in 28-day outcomes for very low birth weight infants: an analysis of 11 neonatal intensive care units Pediatrics 82 1988 554 559
23. ME Msall GM Buck BT Rogers DP Merke CC Wan N Catanzaro Multivariate risks among extremely premature infants J Perinatol 14 1994 41 47
24. M Palta D Gabbert MR Weinstein ME. Peters Multivariate assessment of traditional risk for chronic lung disease in very low birth weight neonates J Pediatr 119 1991 285 292
25. JJ. Zimmerman Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia Clin Perinatol 22 1995 429 456
26. M Contreras N Hariharan JR Lewandoski W Ciesielski R Koscik JJ. Zimmerman Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia Crit Care Med 24 1996 29 37
27. KL Watterberg DF Carmichael JS Gerdes S Werner C Backstrom S. Murphy Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia J Pediatr 125 1994 264 269
28. KL Watterberg SM. Scott Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia Pediatrics 95 1995 120 125
29. C Korte D Styne TA Merritt D Mayes A Wertz HJ. Helbock Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome J Pediatr 128 1996 257 263
30. RJ Sanders C Cox D Phelps RA. Sinkin Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome Pediatr Res 36 1994 122 128
31. ES Shinwell M Karplus E Zmora D Reich S Rothschild S Blazer Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome Arch Dis Child 74 1996 F33 F37
32. A Rastogi SM Akintorin ML Bez P Morales RS. Pildes A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants Pediatrics 98 1996 204 210
33. E Halac J Halac EF Bégué JM Casañas DR Indiveri JF Petit Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial J Pediatr 117 1990 132 138
34. MS Caplan W. MacKendrick Inflammatory mediators and intestinal injury Clin Perinatol 21 1994 235 246
35. DM Wilson RB Baldwin RL. Ariagno A randomized, placebo controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants J Pediatr 113 1988 764 768
36. JJ Cummings DB D'Eugenio SJ. Gross A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia N Engl J Med 320 1989 1505 1510